No Data
Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy
Avant Technologies Ends AI Healthcare Joint Venture Agreement
Express News | Avai Bio Inc - AI-Nova Acquisition Corp. to Be Formally Dissolved - SEC Filing
Express News | Avai Bio Inc - Co and Ainnova Tech Mutually Terminate Joint Venture and License Agreement on May 7, 2026 - SEC Filing
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step